Management of multidrug-resistant enterococcal infections - Test2 - elhamkhani - TriplyDB

Management of multidrug-resistant enterococcal infections

Management of multidrug-resistant enterococcal infections

http://www.wikidata.org/entity/Q28285907

about

Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia Genome-wide identification of ampicillin resistance determinants in Enterococcus faecium Comparison of Enterococcus faecium and Enterococcus faecalis Strains isolated from water and clinical samples: antimicrobial susceptibility and genetic relationships Characterization of Enterococcus faecalis phage IME-EF1 and its endolysin SURVEILLANCE FOR VANCOMYCIN RESISTANT ENTEROCOCCI IN A TERTIARY INSTITUTION IN SOUTH WESTERN NIGERIA.Rapid Identification of Vancomycin Resistant Enterococcus Faecalis Clinical Isolates using a Sugar Fermentation Method.Molecular Mechanism of Quorum-Sensing in Enterococcus faecalis: Its Role in Virulence and Therapeutic Approaches Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis.Antibiotics and bacterial resistance in the 21st century.Accurate delivery of chemicals and intense light on infected areas only for targeted therapy inside the body.Aquaculture can promote the presence and spread of antibiotic-resistant Enterococci in marine sediments.Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.Invasive gram-positive bacterial infection in cancer patients.Development of a DNA microarray for enterococcal species, virulence, and antibiotic resistance gene determinations among isolates from poultry.Development and evaluation of a Quadruplex Taq Man real-time PCR assay for simultaneous detection of clinical isolates of Enterococcus faecalis, Enterococcus faecium and their vanA and vanB genotypes.The rising problem of antimicrobial resistance in the intensive care unit.Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013).Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients Real-World Treatment of Enterococcal Infections with Daptomycin: Insights from a Large European Registry (EU-CORE)Differential Effects of Penicillin Binding Protein Deletion on the Susceptibility of Enterococcus faecium to Cationic Peptide Antibiotics Monitoring of antibiotic resistance in bacteria isolated from laboratory animals Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.Deletion of liaR Reverses Daptomycin Resistance in Enterococcus faecium Independent of the Genetic Background The Two-Component System ChtRS Contributes to Chlorhexidine Tolerance in Enterococcus faecium Chitosan-propolis nanoparticle formulation demonstrates anti-bacterial activity against Enterococcus faecalis biofilms Intrinsic and acquired resistance mechanisms in enterococcus.Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapy Genetic mechanisms of antimicrobial resistance identified in Salmonella enterica, Escherichia coli, and Enteroccocus spp. isolated from U.S. food animals A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant Enterococcus faecalis.Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids.Characterisation of Phenotypic and Genotypic Antibiotic Resistance Profile of Enterococci from Cheeses in Turkey Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections.Co-diversification of Enterococcus faecium Core Genomes and PBP5: Evidences of pbp5 Horizontal Transfer.Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).Safety of the surrogate microorganism Enterococcus faecium NRRL B-2354 for use in thermal process validation.Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections.Biogenesis of [Fe-S] cluster in Firmicutes: an unexploited field of investigation.

P2860

Q26798630-E35CD948-7CD7-45F4-BBC0-757FC6563CF5 Q26851754-2ED54001-DF97-41B6-8E8E-923D0525EF5B Q28302184-1F06C699-98F9-4E2B-8307-04E739618CCC Q28480857-C028E922-C580-46DB-AF11-5D8374012921 Q28485875-C44AF408-AB8A-4848-9BFF-C2D1DEC7EA7F Q28535077-31FE62CC-2E08-4DF2-967E-A36FCC121493 Q33623378-761E237F-E4CC-4237-A254-FC6955DB74BC Q33666289-E72D7551-423A-4737-ADD3-32A7633D6225 Q33754949-8FAC0823-331D-4899-8E5D-377DE6262CFB Q34057475-3BFB35D3-D207-4BF8-9E1B-27C19043EDB6 Q34156349-95F4ABB7-521B-442D-9173-C0E03DADC299 Q34349305-B04507C7-2313-44B8-93DF-BD5DAA73324C Q34702040-F88A3251-F440-4730-9E3B-173AC8FE7E84 Q34728711-B6AC94C0-DC03-4FAF-BB1A-58575A1FB7EB Q34999884-82B09957-0FDD-4504-BDD4-A06DBDBE2377 Q35077165-1A99AD54-0690-4035-B088-F5B515705B77 Q35270753-9A4A25AE-471E-4DE1-B5F1-14D9EE39BF08 Q35595833-B3846C54-053D-43A4-B765-8A095DF07BD4 Q35746080-0CDAAC76-5F00-42F7-8297-4579EE0D02D9 Q35941296-C735DC05-FAB5-4A25-9181-C262EB14C88C Q35999714-B138E369-8EC8-40F3-9E47-95C0A15915D8 Q36073400-5E7F8D62-903B-4BF9-9ED3-2D5E9637C852 Q36075839-EFE214B0-B883-462E-B74B-6D303D23C5A8 Q36076562-DBCFED2E-FA98-4FAC-BF21-4DE438DA3797 Q36171704-DCB87693-A6FB-4112-BA68-6463849F9BB6 Q36290600-10BC4A20-0783-426C-AABF-D524D1EAA46E Q36292464-85DA0519-31DF-4526-803E-A5372DBCDA48 Q36330299-45A7F94A-C4CD-43EA-92D1-A343A135BAF1 Q36362547-240D0E5C-B492-4F53-A285-71AF467C5133 Q36505376-B83AB8DE-0500-4349-A91B-F38B1A4C6CCA Q36868647-D20AB413-E4F2-43F8-9D2C-5AD649A2968A Q37026557-D6045583-FB3E-43FC-BA0F-89232F8D3A62 Q37074688-C175F12E-7C6D-4BE4-9642-30A61E88231C Q37088957-03F80E4A-D27C-433D-8B57-8F1975BA8147 Q37263709-85FEF875-EEB3-4470-A270-7564106DD0A4 Q37316094-A357CE9D-7064-4DA0-9F99-2840D85F429E Q37377897-0D9DBCD9-A9A3-4657-90F3-6F7ECD9489D7 Q37643273-5DA6B103-0321-46A3-83EC-4B7C9F71744C Q38088261-7046B29E-7BFE-4374-BE9E-70055CC0DD05 Q38121426-BE08DD16-8863-4B69-A469-8BDCCFE4126B

P2860

Management of multidrug-resistant enterococcal infections

http://www.wikidata.org/entity/Q28285907

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Management of multidrug-resistant enterococcal infections

@ast

Management of multidrug-resistant enterococcal infections

@en

Management of multidrug-resistant enterococcal infections

@nl

type

label

Management of multidrug-resistant enterococcal infections

@ast

Management of multidrug-resistant enterococcal infections

@en

Management of multidrug-resistant enterococcal infections

@nl

prefLabel

Management of multidrug-resistant enterococcal infections

@ast

Management of multidrug-resistant enterococcal infections

@en

Management of multidrug-resistant enterococcal infections

@nl

P1433

Q28285907-CC5BD0B1-1A72-4E2D-9AAC-4F5381B9F616

P1476

Q28285907-B053D298-6A59-4FCA-8213-096E39238409

P2093

Q28285907-1DD0CE5E-2D73-489E-82CC-0E9A11C609D6

Q28285907-618DC338-AA95-490E-BBF0-67D6B3553B98

Q28285907-D4A58468-8F00-4D09-BCDE-3F93F2DB5010

P2860

Q28285907-037D006D-B0B7-4972-84F4-CE8B4F0A55C0

Q28285907-049A46D5-B984-4944-B066-11FF4BE8E2DB

Q28285907-058D76B7-BACD-4C27-9BEE-352636357E6D

Q28285907-07E8EE64-23D7-435D-A302-97308D1989B4

Q28285907-09EDA97B-A453-4BF8-B28C-6081A6229287

Q28285907-0B733152-D05F-45D0-8BAE-A3F90600F5EE

Q28285907-0DB4017E-C555-4D68-9E35-FEFA95554E8D

Q28285907-1032CEA0-88F1-4102-B7B2-E6AB6DEAACF6

Q28285907-14871D2F-737F-4B90-947A-77B7922C074C

Q28285907-19595910-D738-4416-A1BE-990F9E247A41

P304

Q28285907-B7F0BE1F-B33C-4032-9FB2-D2E482D9EA62

P31

Q28285907-1B3D2732-FF15-46DE-8B6F-FFCBD3BE18AD

P3181

Q28285907-C5F8C9E0-64D4-407A-BBE1-07CBE0EFF3D6

P356

Q28285907-D9C12ACF-6EF9-4C3B-BF88-18DB2C95D627

P407

Q28285907-7394F398-721E-4962-9E41-1803E17948E1

P433

Q28285907-3F032A5B-B1F4-4866-B2FF-68474127821C

P478

Q28285907-9BF258BA-5FB2-4E5B-BF27-3A7C2F9C00C0

P577

Q28285907-F088BB12-615B-49E3-ACD1-DC7B45C19664

P5875

Q28285907-125B852D-3CC8-4EE0-9C1E-C00EB78A7DBB

P698

Q28285907-9F20D324-F971-4B2A-B01D-15BD63868E73

P921

Q28285907-CC7882D7-99FC-477F-B6C4-11DAEC85D2E4

Q28285907-E606A4E2-5EFF-4EEE-8315-FE880AD21BD8

P932

Q28285907-E9A8E4BA-C0C6-4476-8BB5-41907E56987A

P3181

P356

J.1469-0691.2010.03214.X

P1433

Clinical Microbiology and Infection

P1476

Management of multidrug-resistant enterococcal infections

@en

P2093

B E Murray

http://www.w3.org/2001/XMLSchema#string

C A Arias

http://www.w3.org/2001/XMLSchema#string

G A Contreras

http://www.w3.org/2001/XMLSchema#string

P2860

Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus

Vancomycin-resistant Enterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factors

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.

Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program.

Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence.

Differences in the Enterococcus faecalis lsa locus that influence susceptibility to quinupristin-dalfopristin and clindamycin

Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis

Beta-lactamase-producing enterococci.

Vancomycin-resistant enterococcal infections.

P304

555-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

366550

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/J.1469-0691.2010.03214.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44693693

http://www.w3.org/2001/XMLSchema#string

P698

20569266

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

multiple drug resistance

P932

3686902

http://www.w3.org/2001/XMLSchema#string